Target intelligence / Profile preview

Ocular surface (Tear film and corneal epithelium) (OS)

Target
OS
Molecular classification
Complex anatomical system, Mucin glycoproteins, Lipid layer, Aqueous layer, Cellular barrier
01

Overview

The ocular surface tear film and corneal epithelium constitute a complex functional unit essential for maintaining visual clarity and ocular health. The tear film is a trilayered structure consisting of an outer lipid layer produced by meibomian glands, a middle aqueous layer from lacrimal glands, and an inner mucin layer secreted by goblet cells and the corneal epithelium. This system provides a smooth refractive surface, lubricates the eyelids, and serves as a primary defense barrier against pathogens and environmental insults. Dysfunction in any component of this system leads to ocular surface diseases, most notably dry eye disease, characterized by inflammation, hyperosmolarity, and epithelial damage. Therapeutic interventions range from palliative lubricants to immunomodulators that target the underlying inflammatory cycle to restore the homeostatic balance of the ocular surface environment.

Other names
Ocular surface systemPrecorneal tear filmCorneal epithelial barrierOcular surface unit
02

Mechanism of action

Drugs targeting this system typically act by modulating inflammatory pathways (e.g., T-cell inhibition via Cyclosporine), blocking integrin-mediated lymphocyte adhesion (Lifitegrast), stimulating natural tear production via nicotinic acetylcholine receptors (Varenicline), or providing physical lubrication and osmoprotection (artificial tears).

03

Biological functions

RefractionLubricationMechanical protectionImmune defenseHydrationWound healing
04

Disease associations

Dry eye disease (Keratoconjunctivitis sicca)Sjögren's syndromeCorneal ulcerKeratitisMeibomian gland dysfunctionOcular graft-versus-host disease
05

Safety considerations

Ocular stinging or burningBlurred visionIncreased risk of secondary ocular infectionToxicity from preservatives (e.g., Benzalkonium chloride)Dysgeusia (with nasal sprays or certain drops)
06

Interacting drugs

Cyclosporine

7 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT)Schirmer test scoreOcular Surface Disease Index (OSDI)Tear osmolarityCorneal staining (Fluorescein/Lissamine green)MMP-9 levels

Beyond the preview

Go deeper on Ocular surface (Tear film and corneal epithelium) (OS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface (Tear film and corneal epithelium) (OS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call